(Cochrane) Seguridad y eficacia de los vasodilatadores en paciente con síndrome de Raynaud https://t.co/sh7oMsJjUC
(Cochrane) Seguridad y eficacia de los vasodilatadores en pac con síndrome de Raynaud https://t.co/RC6Uo4hpvT https://t.co/x8Pg5XCnma
Les médicaments vasodilatateurs dans la réduction des symptômes du phénomène de Raynaud primaire https://t.co/BiQHedwmLt
Vasodilatadores en síndrome de Raynaud via @rincondesisifo
RT @rincondesisifo: (Cochrane) Vasodilatadores en síndrome de Raynaud https://t.co/MociJsytpL https://t.co/uUqUTLpSfk
(Cochrane) Vasodilatadores en síndrome de Raynaud https://t.co/MociJsytpL https://t.co/uUqUTLpSfk
@CochraneVasc Les preuves sont insuffisantes pour soutenir l’utilisation de vasodilatateurs (hors ICA) et suggèrent qu ils peuvent même aggraver le phénomène de Raynaud primaire. https://t.co/5TwVAXVioJ
RT @CochraneUK: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/uZCGQFUXMo Updated @CochraneVasc syst…
RT @CochraneUK: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/uZCGQFUXMo Updated @CochraneVasc syst…
RT @CochraneUK: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/uZCGQFUXMo Updated @CochraneVasc syst…
RT @CochraneUK: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/uZCGQFUXMo Updated @CochraneVasc syst…
RT @CochraneVasc: #CochraneEvidence updated primary #raynaudsdisease https://t.co/T0HiMtOwHI @IrishRaynauds @RaynaudsRf @WeAreSRUK @scotr…
RT @CochraneVasc: #CochraneEvidence updated primary #raynaudsdisease https://t.co/T0HiMtOwHI @IrishRaynauds @RaynaudsRf @WeAreSRUK @scotr…
RT @cochrane_nz: Updated Review: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/vs6UyL5PFs Updated @…
Updated Review: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/vs6UyL5PFs Updated @CochraneVasc systematic review looks at the evidence from 15 studies with 635 participants. #RaynaudsPhenomenon #RaynaudsCondition
RT @CochraneLibrary: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/hZN35LIFC6 Updated @CochraneVasc…
Legemidler for #likfingre https://t.co/9mkIk69MpM
RT @CochraneLibrary: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/hZN35LIFC6 Updated @CochraneVasc…
Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/hZN35LIFC6 Updated @CochraneVasc systematic review looks at the evidence from 15 studies with 635 participants. #RaynaudsPhenomenon #RaynaudsCondition
Updated #Cochrane Review on #vasodilators for #Raynauds "Evidence is insufficient to support the use of vasodilators and suggests that vasodilator use may even worsen disease." @gin_member https://t.co/EkmFvnsT2i
RT @CochraneUK: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/uZCGQFUXMo Updated @CochraneVasc syst…
RT @CochraneUK: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/uZCGQFUXMo Updated @CochraneVasc syst…
RT @CochraneUK: Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon https://t.co/uZCGQFUXMo Updated @CochraneVasc syst…
RT @CochraneVasc: #CochraneEvidence updated primary #raynaudsdisease https://t.co/T0HiMtOwHI @IrishRaynauds @RaynaudsRf @WeAreSRUK @scotr…
RT @CochraneVasc: #CochraneEvidence updated primary #raynaudsdisease https://t.co/T0HiMtOwHI @IrishRaynauds @RaynaudsRf @WeAreSRUK @scotr…
RT @CochraneVasc: #CochraneEvidence updated primary #raynaudsdisease https://t.co/T0HiMtOwHI @IrishRaynauds @RaynaudsRf @WeAreSRUK @scotr…
RT @CochraneVasc: #CochraneEvidence updated primary #raynaudsdisease https://t.co/T0HiMtOwHI @IrishRaynauds @RaynaudsRf @WeAreSRUK @scotr…
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
@lasfmv @SevestreMarie @ClubVasculaire @MichelDadon @lina_2411
RT @CochraneVasc: #CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.c…
#CochraneEvidence - Vasodilator drugs to reduce the symptoms of primary Raynaud's phenomenon @CochraneLibrary https://t.co/SuSAqZtwv1 Updated systematic review looks at the evidence from 15 studies with 635 participants. #RaynaudsPhenomenon #RaynaudsCondit
Vasodilators for primary Raynaud's phenomenon https://t.co/3DLTyKtnWj